CompletedPhase 2NCT00499473

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Studying Anaplastic astrocytoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Robert Cavaliere
Ohio State University
Intervention
sunitinib malate(drug)
Enrollment
31 enrolled
Eligibility
18 years · All sexes
Timeline
20072014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00499473 on ClinicalTrials.gov

Other trials for Anaplastic astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Anaplastic astrocytoma

← Back to all trials